Login / Signup

Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus.

Hiurma Sánchez-PérezJuan C Quevedo-AbeledoBeatriz Tejera-SeguraLaura de Armas-RilloIñigo Rúa-FigueroaMiguel Angel González-GayIván Ferraz-Amaro
Published in: Therapeutic advances in musculoskeletal disease (2020)
PCSK9 is downregulated in SLE compared with controls, but SLE patients with higher disease activity and damage exhibited higher PSCK9 serum levels.
Keyphrases
  • disease activity
  • systemic lupus erythematosus
  • rheumatoid arthritis
  • rheumatoid arthritis patients
  • low density lipoprotein
  • ankylosing spondylitis
  • oxidative stress
  • juvenile idiopathic arthritis